These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 33332889)

  • 1. Adherence to gout guidelines: where do we stand?
    Ho GH; Pillinger MH; Toprover M
    Curr Opin Rheumatol; 2021 Mar; 33(2):128-134. PubMed ID: 33332889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming adherence issues and other barriers to optimal care in gout.
    Nasser-Ghodsi N; Harrold LR
    Curr Opin Rheumatol; 2015 Mar; 27(2):134-8. PubMed ID: 25633242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence and persistence to urate-lowering therapies in the Irish setting.
    McGowan B; Bennett K; Silke C; Whelan B
    Clin Rheumatol; 2016 Mar; 35(3):715-21. PubMed ID: 25409858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and design of the randomized evaluation of an Ambulatory Care Pharmacist-Led Intervention to Optimize Urate Lowering Pathways (RAmP-UP) Study.
    Coburn BW; Cheetham TC; Rashid N; Chang JM; Levy GD; Kerimian A; Low KJ; Redden DT; Bridges SL; Saag KG; Curtis JR; Mikuls TR
    Contemp Clin Trials; 2016 Sep; 50():106-15. PubMed ID: 27449546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician adherence to ACR gout treatment guidelines: perception versus practice.
    Oderda GM; Shiozawa A; Walsh M; Hess K; Brixner DI; Feehan M; Akhras K
    Postgrad Med; 2014 May; 126(3):257-67. PubMed ID: 24918810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence and Outcomes with Urate-Lowering Therapy: A Site-Randomized Trial.
    Mikuls TR; Cheetham TC; Levy GD; Rashid N; Kerimian A; Low KJ; Coburn BW; Redden DT; Saag KG; Foster PJ; Chen L; Curtis JR
    Am J Med; 2019 Mar; 132(3):354-361. PubMed ID: 30503879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nurse-led care is preferred over GP-led care of gout and improves gout outcomes: results of Nottingham Gout Treatment Trial follow-up study.
    Fuller A; Jenkins W; Doherty M; Abhishek A
    Rheumatology (Oxford); 2020 Mar; 59(3):575-579. PubMed ID: 31410473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urate-lowering therapy adherence and the association with medication beliefs, self-efficacy, depression, anxiety, and COVID-19 pandemic-related concern in Chinese gout patients: a cross-sectional study.
    Yin R; Lu J; Xu Z; Yan Q; Wang M; Xu R
    Psychol Health Med; 2023; 28(7):1698-1708. PubMed ID: 37322811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are Doctors the Best People to Manage Gout? Is There a Role for Nurses and Pharmacists?
    Latif Z; Abhishek A
    Curr Rheumatol Rep; 2018 Mar; 20(3):14. PubMed ID: 29516289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gout medication treatment patterns and adherence to standards of care from a managed care perspective.
    Sarawate CA; Brewer KK; Yang W; Patel PA; Schumacher HR; Saag KG; Bakst AW
    Mayo Clin Proc; 2006 Jul; 81(7):925-34. PubMed ID: 16835972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rebranding Gout: Could a Name Change for Gout Improve Adherence to Urate-Lowering Therapy?
    Coleshill MJ; Aung E; Carland JE; Faasse K; Stocker S; Day RO
    Ther Innov Regul Sci; 2021 Jan; 55(1):138-141. PubMed ID: 32661926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Response or Non-response to Urate-Lowering Therapy in Patients with Gout.
    Graham GG; Stocker SL; Kannangara DRW; Day RO
    Curr Rheumatol Rep; 2018 Jun; 20(8):47. PubMed ID: 29931553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term persistence and adherence on urate-lowering treatment can be maintained in primary care-5-year follow-up of a proof-of-concept study.
    Abhishek A; Jenkins W; La-Crette J; Fernandes G; Doherty M
    Rheumatology (Oxford); 2017 Apr; 56(4):529-533. PubMed ID: 28082620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring of Urate-Lowering Therapy Among US Veterans Following the 2012 American College of Rheumatology Guidelines for Management of Gout.
    Hughes JC; Wallace JL; Bryant CL; Salvig BE; Fourakre TN; Stone WJ
    Ann Pharmacother; 2017 Apr; 51(4):301-306. PubMed ID: 27881692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Achieving serum urate targets in gout: an audit in a gout-oriented rheumatology practice.
    Corbett EJM; Pentony P; McGill NW
    Int J Rheum Dis; 2017 Jul; 20(7):894-897. PubMed ID: 28205336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication adherence among patients with gout: A systematic review and meta-analysis.
    Scheepers LEJM; van Onna M; Stehouwer CDA; Singh JA; Arts ICW; Boonen A
    Semin Arthritis Rheum; 2018 Apr; 47(5):689-702. PubMed ID: 29198878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to urate-lowering therapy.
    Day RO
    South Med J; 2009 Jan; 102(1):114-5. PubMed ID: 19077754
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of Gout in a Hospital Setting: A Lost Opportunity.
    Wright S; Chapman PT; Frampton C; O'Donnell JL; Raja R; Stamp LK
    J Rheumatol; 2017 Oct; 44(10):1493-1498. PubMed ID: 28765252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient perspectives in gout: a review.
    Singh JA
    Curr Opin Rheumatol; 2019 Mar; 31(2):159-166. PubMed ID: 30575598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate of adherence to urate-lowering therapy among patients with gout: a systematic review and meta-analysis.
    Yin R; Li L; Zhang G; Cui Y; Zhang L; Zhang Q; Fu T; Cao H; Li L; Gu Z
    BMJ Open; 2018 Apr; 8(4):e017542. PubMed ID: 29643150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.